Expression of mdr-1 gene in transitional cell carcinoma and its correlation with chemotherapy response

Journal of Urology

Volumn 156, Issue 1, 1996, Pages 271-275

  Pu, Yeong Shiau ^a   Tsai, Tsong Chang ^a   Cheng, Ann Lii ^a   Tsai, Chia Ying ^a   Tseng, Nuan Fang ^a   Su, I H Jen ^a   Hsieh, Chang Yao ^a   Lai, Ming Kuen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

carcinoma, transitional cell; drug resistance; drug therapy

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; METHOTREXATE; VERAPAMIL; VINBLASTINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; CANCER RESISTANCE; CYSTECTOMY; DOSE RESPONSE; GENE EXPRESSION; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0029977063     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66015-4     Document Type: Article

References (22)

1. Pastan, I. and Gottesman, M.: Multiple-drug resistance in human cancer. N. Eng. J. Med., 316: 1388, 1987.
2. Rothenberg, M. and Ling, V.: Multidrug resistance: molecular biology and clinical relevance. J. Natl. Cancer Inst., 81: 907, 1989.
3. Deuchars, K. L. and Ling, V.: P-glycoprotein and multidrug resistance in cancer chemotherapy. Semin. Oncol., 16: 156, 1989.
4. Weinstein, R. S., Kuszak, J. R., Kluskens, L. F. and Coon, J. S.: P-glycoprotein in pathology: the multidrug resistance gene family in humans. Human Pathol., 21: 34, 1990.
5. Naito, S., Sakamoto, N., Kotoh, S., Goto, K., Matsumoto, T. and Kumazawa, J.: Correlation between the expression of P-glycoprotein and multidrug-resistant phenotype in transitional cell carcinoma of the urinary tract. Eur. Urol., 22: 158, 1992.
6. Kimiya, K., Naito, S., Soejima, T., Sakamoto, N., Kotoh, S., Kumazawa, J. and Tsuruo, T.: Establishment and characterization of doxorubicin-resistant human bladder cancer cell line KK47/ADM. J. Urol., 148: 441, 1992.
7. Sandlow, J., Cohen, M. B., Robinson, R. A., Dreicer, R. and Williams, R. D.: DNA ploidy and P-glycoprotein expression as predictive factors of response to neoadjuvant chemotherapy for invasive bladder cancer. Urology, 43: 787, 1994.
8. Park, J., Shinohara, N., Liebert, M., Noto, L., Flint, A. and Grossman, H. B.: P-glycoprotein expression in bladder cancer. J. Urol., 151: 43, 1994.
9. Ohi, Y., Ohmori, H., Shirahama, T., Kawahara, M., Matsumura, Y., Tsushima, T. and Ohashi, Y.: Intravesical instillation of adriamycin in the presence or absence of verapamil for the treatment of superficial bladder cancer: preliminary report of a collaborative study. Cancer Chemother. Pharmacol., 30: S50, 1992.
10. Yu, H.-J., Tsai, T.-C., Hsieh, T.-S. and Chiu, T.-Y.: Characterization of a newly established human bladder carcinoma cell line, NTUB1. J. Formos. Med. Assoc., 91: 608, 1992.
11. Chen, C.-J., Chuang, Y.-C., You, S.-L., Lin, T.-M. and Wu, H.-Y.: A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer, 53: 399, 1986.
12. Yu, D.-S., Yeh, M-Y., Chen, S.-C., Lin, M.-S., Chang, S.-Y., Ma, C.-P. and Han, S.-H.: Establishment and characterization of a human urinary bladder carcinoma cell line (TSGH-8301). J. Surg. Oncol., 37: 177, 1988.
13. Pu, Y.-S., Hsieh, T.-S., Tsai, T.-C., Cheng, A.-L., Hsieh, C.-Y., Su, I.-J. and Lai, M.-K.: Tamoxifen enhances the chemosensitivity of bladder carcinoma cells. J. Urol., 154: 601, 1995.
14. Chomczynski, P. and Sacchi, N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156, 1987.
15. Höltke, H. J., Sagner, G., Kessler, C. and Schmitz, G.: Sensitive chemiluminescent detection of digoxigenin-labeled nucleic acids: a fast and simple protocol and its applications. Biotechnology (N.Y.), 12: 104, 1992.
16. Lion, T. and Haas, O.: Nonradioactive labeling of probe with digoxigenin by polymerase chain reaction. Anal. Biochem., 188: 335, 1990.
17. Neyfakh, A. A.: Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exper. Cell Res., 174: 168, 1988.
18. Efferth, T., Lohrke, H. and Volm, M.: Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors. Anticancer Res., 9: 1633, 1989.
19. Ludescher, C., Thaler, J., Drach, D., Drach, J., Spitaler, M., Gattringer, C., Huber, H. and Hofmann, J.: Detection of activity of P-glycoprotein in human tumor samples using rhodamine 123. Br. J. Haematol., 82: 161, 1992.
20. Slater, L. M., Murray, S. L., Wetzel, M. W., Wisdom, R. M. and DuVall, E. M.: Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma. J. Clin. Invest., 70: 1131, 1982.
21. Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T. and Carbone, P. P.: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol., 5: 649, 1982.
22. Theyer, G., Schirmböck, M., Thalhammer, T., Sherwood, E. R., Baumgartner, G. and Hamilton, G.: Role of the mdr-1 encoded multiple drug resistance phenotype in prostate cancer cell lines. J. Urol., 150: 1544, 1993.